Gilead Sciences GILD Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Gilead Sciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gilead Sciences's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gilead Sciences's total liabilities & equity?
- Gilead Sciences (GILD) reported total liabilities & equity of $56.28B in Q1 2026.
- How has Gilead Sciences's total liabilities & equity changed year-over-year?
- Gilead Sciences's total liabilities & equity decreased by 0.3% year-over-year, from $56.43B to $56.28B.
- What is the long-term trend for Gilead Sciences's total liabilities & equity?
- Over 5 years (2020 to 2025), Gilead Sciences's total liabilities & equity has grown at a -2.9% compound annual growth rate (CAGR), from $68.41B to $59.02B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.